Home > Insider Trading > Filing (0001567619-21-005535)

Filing Details

Accession Number:: 0001567619-21-005535
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-03-03 16:41:57
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-03 16:41:57
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1444380	Nevro Corp	NVRO	Surgical & Medical Instruments & Apparatus (3841)	562568057

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1635670	Brad Vale	C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2021-03-01	503	$166.05	11,831	No	4	S	Direct
Common Stock	Disposition	2021-03-01	2,012	$167.04	9,819	No	4	S	Direct
Common Stock	Disposition	2021-03-01	1,278	$168.32	8,541	No	4	S	Direct
Common Stock	Disposition	2021-03-01	1,510	$169.08	7,031	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $165.49 to $166.405, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Includes 1,376 restricted stock units.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $166.64 to $167.15, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $167.86 to $168.767, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $168.905 to $169.68, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.